• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women with adhd medication adderall uk, head to Chessdatabase, face a difficult decision about whether to continue or stop taking ADHD medication during pregnancy and breast-feeding. Little data exists about how to get medication for adhd uk long-term exposure to these medications may affect the foetus.

A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication in utero do not develop neurological conditions like hearing or vision impairment seizures, febrile seizures or IQ impairment. The authors acknowledge that more high quality studies are required.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medication need to weigh the benefits of taking it against the possible risks for the foetus. The doctors don't have the information to make unambiguous recommendations, but can provide information on risks and benefits to aid pregnant women in making informed decisions.

A study published in Molecular Psychiatry found that women who were taking ADHD medications during early pregnancy did not face an higher risk of fetal cardiac malformations or major structural birth defects. The researchers used a large population-based study of case-control to determine the prevalence of major structural birth defects in infants born to mothers who took stimulants during the early stages of pregnancy and those who had not. Clinical geneticists and pediatric cardiologists reviewed the cases to ensure correct classification of the cases and to reduce the chance of bias.

The study conducted by the researchers had some limitations. Researchers were unable, in the first place to differentiate the effects of the medication from the disorder. This makes it difficult to determine whether the small differences observed in the exposed groups result from medication use or the confounding effect of comorbidities. Additionally the researchers did not examine the long-term outcomes of offspring.

The study showed that infants whose mother took ADHD medication during pregnancy had a higher risk of admission to the neonatal care unit (NICU) in comparison to those whose mothers did not use any medication during pregnancy, or had quit taking the medication prior to or during pregnancy. The reason for this was central nervous system disorders. The increased risk of admission was not affected by the stimulant medication used during pregnancy.

Women who were taking stimulant ADHD medications during pregnancy also had a higher chance of having a caesarean section or the baby was not scoring well on the Apgar scale (less than 7). These increases did not seem to be influenced by the kind of best medication for adhd used during pregnancy.

Researchers suggest that the minor risk of using ADHD medications in early pregnancies could be offset by the greater benefits to both baby and mother of continued treatment for the woman's disorder. Physicians should talk to their patients about this issue and try to help them develop coping strategies that could reduce the impact of her disorder in her daily life and relationships.

Medication Interactions

More and more doctors are confronted with the dilemma of whether to keep treatment or stop as more women are diagnosed with ADHD. These decisions are often made without clear and authoritative evidence. Instead, doctors have to consider their own expertise, the experience of other physicians and the research on the subject.

The issue of possible risks to infants is difficult to determine. Many studies on this subject are based on observational evidence rather than controlled research and their conclusions are often contradictory. Furthermore, most studies restrict their analysis to live births, which may undervalue the serious teratogenic effects that can lead to abortion or termination of the pregnancy. The study presented in the journal club addresses these limitations by analyzing data on live and deceased births.

Conclusion Some studies have found an association between ADHD medications and certain birth defects, other studies have not found a correlation. Most studies have shown a neutral, or even somewhat negative, impact. In the end an accurate risk-benefit analysis must be done in each situation.

It can be difficult, if not impossible for women with ADHD to stop taking their medication. In a recent article published in the Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can cause depression and feelings of being isolated. A decrease in medication could also impact the ability to drive safely and complete work-related tasks, which are crucial aspects of everyday life for those suffering from ADHD.

She suggests women who are uncertain about whether or not to stop medication in light of their pregnancy consider informing family members, friends and colleagues on the condition, its impact on daily life, and the advantages of staying on the current treatment plan. It will also help a woman feel more confident in her decision. Certain medications can be passed through the placenta. If a patient decides to stop taking her ADHD medication while breastfeeding, it is important to be aware that the drug may be transferred to her baby.

Birth Defects and Risk of

As the use of ADHD drugs to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases, so do concerns about what impact the medications could have on fetuses. A study that was published in the journal Molecular Psychiatry adds to the existing knowledge on this subject. Utilizing two huge data sets, researchers were able to look at more than 4.3 million pregnancies to determine whether the use of stimulant medications increased the risk of birth defects. Although the risk overall remains low, the scientists did find that first-trimester exposure to strongest adhd medication for adults medications was linked to a slightly higher rate of certain heart defects, like ventriculo-septal defects (VSD).

The researchers of the study could not discover any link between the use of early medications and other congenital anomalies like facial deformities or club feet. The results are in line with previous studies that have shown an increase, but not significant, in the risk of cardiac malformations among women who began taking ADHD medications prior to the time of the birth of their child. The risk was higher in the latter half of pregnancy, when many women are forced to stop taking their ADHD medication.

Women who took ADHD medication during the first trimester were more likely require a caesarean birth and also have an insufficient Apgar after birth and have a baby that needed help breathing when they were born. However the authors of the study were not able to eliminate bias due to selection by limiting the study to women who didn't have any other medical conditions that could be a contributing factor to these findings.

The researchers hope their study will aid in the clinical decisions of physicians who treat pregnant women. They advise that while discussing risks and benefits is important, the decision to stop or keep medication should be based on the woman's requirements and the severity of her ADHD symptoms.

The authors also caution that even though stopping the medication is an option, it isn't a recommended practice because of the high rate of depression and other mental health issues among women who are pregnant or postpartum. Furthermore, research suggests that women who choose to stop taking their medication are more likely to have difficulties adjusting to life without them following the birth of their baby.

Nursing

It can be a stressful experience becoming a mother. Women suffering from ADHD can face severe challenges when they must deal with their symptoms, attend doctor appointments, prepare for the birth of a baby and adjust to a new routine. This is why many women choose to continue taking their ADHD medication throughout the pregnancy.

The majority of stimulant medications are absorbed through breast milk in very small amounts, so the risk for breastfeeding infant is minimal. The rate of medication exposure will differ based on dosage, frequency of administration and time of day. In addition, different medications enter the baby’s system through the gastrointestinal tract, or through breast milk. The impact on a newborn's health is not fully comprehended.

Some doctors may decide to stop stimulant medication for adhd and bipolar during a woman's pregnancy due to the lack of research. This is a difficult decision for the woman, who must weigh the advantages of continuing her medication against the risks to the foetus. As long as more information is available, GPs can ask pregnant patients if they have a history of ADHD or if they intend to take medication in the perinatal period.

A growing number of studies have revealed that the majority of women are able to safely continue taking their ADHD medication while they are pregnant and nursing. In the end, many patients opt to do this, and after consulting with their doctor, they have found that the benefits of maintaining their current medication exceed any risk.

It's important for women with ADHD who are considering breastfeeding to seek a specialist psychiatrist's advice prior to becoming pregnant. They should review their medications with their prescriber and discuss the pros and cons of continued treatment, including non-pharmacological management strategies. Psychoeducation should also be offered to help pregnant people with ADHD understand their symptoms and the underlying disorder and learn about treatment options and strengthen existing strategies for coping with adhd without medication. This should be a multidisciplinary approach with the GP as well as obstetricians, psychiatry and obstetricians. Pregnancy counseling should consist of a discussion of a treatment plan for the mother as well as the child, and monitoring for signs of deterioration and, if needed modifications to the medication regime.